Merck’s new BioReliance® Facility in Darmstadt: supporting biologics development and commercialization in Europe
Merck’s new BioReliance® Facility in Darmstadt, Germany, will support biologics testing, GMP release testing and stability studies in Europe. The post Merck’s new BioReliance® Facility in Darmstadt: supporting biologics development and commercialization in Europe appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express…
We haven't written up this one. Labiotech has the full story — the link below goes straight to it.
